Article citationsMore>>

Liaw, C.C, Wang, C.H., Yang, T.S., Chen, J.S., Chang, H.K., Lin, Y.C., et al. (1999) Risk of Transient Hyperammonemic Encephalopathy in Cancer Patients Who Received Continuous Infusion of 5 Fluorouracil with the Complication of Dehydration and Infection. Anticancer Drugs, 31, 605-609.
https://doi.org/10.1097/00001813-199903000-00004

has been cited by the following article:

• TITLE: 5-Fluorouracil-Induced Hyperammonemia Encephalopathy in a Patient with Gastric Cancer

  AUTHORS: Toky Rakotoarivo, Vonjy Andrianarison, Ny Ony Andrianandrasana, Malala Razakanaivo, Florine Rafaramino

  KEYWORDS: Encephalopathy, Gastric Cancer, Hyperammonemia, 5-Fluororuracil

  JOURNAL NAME: Journal of Cancer Therapy, Vol.14 No.2, February 28, 2023

  ABSTRACT: Chemotherapy with 5-fluorouracil (5 FU) has been widely used to treat advanced gastric cancer. Knowing the side effects is therefore important in order to better prevent them. Fluoropyrimidine-induced hyperammonemic encephalopathy is a rare complication and characterized neurological status with elevated ammonia level without radiological abnormalities. We report the first case of 5 FU-induced hyperammonemic encephalopathy in women patients on induction chemotherapy for gastric cancer in Madagascar. His ammonia level (NH3) was 102 μmol/l. The patient recovered from his confusional state after two days of treatment with hyperhydration and vitamin therapy.